Duff & Phelps Healthcare and Life Sciences team provides Fortune 500 corporations, middle-market and growth companies and financial sponsors access to our valuation and corporate finance services.
Our dedicated team completes nearly 200 healthcare engagements annually, including engagements in healthcare services, Pharmaceuticals, Medical Technology and Life Sciences. As a firm, Duff & Phelps stands alone in our objectivity, deep technical and industry expertise and breadth of advisory services.
Financial Sponsor Group
Dedicated coverage and access to M&A deal-flow for financial sponsors.
Distressed M&A and Special Situations
Financial and operational solutions for distressed and special situations.
Valuation and asset appraisal for financial reporting, income tax, investment and risk management purposes.
Middle-market M&A advisory differentiated by industry expertise and superior execution.
has completed a debt for equity exchange as part of a restructuring transaction
has completed a recapitalization and financial restructuring transaction
Canadian M&A Insights – Summer 2020
FCA Gains New Powers Over Libor Transition, Industry Still Pushed to Actively Migrate to Alternatives
European Chemicals Update – Q3 2020
Automotive Industry insights – Summer 2020
Srividya Gopal Featured in Mergermarket Talking About M&A Indicators Post COVID-19
David Larsen Talks About LPs Exercising Vigilance
Duff & Phelps Ranked Among Top 5 Financial Advisors in Germany for Q2 2020
Duff & Phelps Partners with NYU Stern School of Business